Skip to main content
. 2011 Apr;6(2):109–113.

Table 1.

Demographic and clinical data of the patients before and after silicone oil removal

No Age (years) Sex Eye Underlying disease Duration of retained silicone oil (months) Duration from oil removal to ERG (days) BCVA a-wave amplitude (μv) b-wave amplitude (μv)

Maximal combined response Rod response Cone response Maximal combined response Rod response Cone response


Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post
1 69 F OD Myopic RRD 23 14 20/200 20/160 28.1 99.2 3.1 14.1 7 6 93.7 244 59.3 144 24.3 84.7

2 54 F OS Myopic RRD 16 16 CF3m CF3m 17.2 26.6 10.8 7.7 6.4 8.7 24.9 63.2 11.7 17.2 13.5 14.6

3 28 M OS Traumatic RRD 7 13 CF2.5m CF3m 47.7 78 10.2 15 10.2 12.3 84.3 205 50.7 98.3 28 54.1

4 26 M OS Traumatic RRD 8 14 20/160 20/160 43 50 10.2 8.7 6 18.9 93.7 312 55.4 90 26.4 53.7

5 21 F OS Pseudophakic RRD 25 13 20/200 20/120 1.6 3.8 6.3 7 1 5.4 10.9 10.8 7.7 7 18.5 14.9

6 12 M OS Myopic RRD 19 12 CF4m CF4m 14.1 37.5 11.7 3.1 5.2 7.4 31.2 37.5 14 14 5.6 7.5

7 31 F OD Myopic RRD 30 13 20/160 20/120 7 16.4 0.8 1.2 4.3 4.5 17.9 38.2 8.5 11.6 7.6 19

8 30 M OD Traumatic RRD 28 14 20/50 20/50 46.1 67.2 7.8 10.2 16.2 14.2 198 266 108 104 44.9 56.2

9 37 M OS Aphakic RRD 32 15 CF3m CF4m 9.4 66.2 1.5 68.8 2.2 8.1 21.8 66.2 5.5 92.9 4.3 9.8

10 52 M OS Traumatic RRD 36 15 CF2m CF2.5m 23.3 6.3 6.9 5.6 2.6 1.2 84.4 64.6 42.2 39.7 9 5.7

11 33 F OD Retinal angiomatosis 27 14 CF1.5m CF2m 37.5 39.1 5.5 5.5 7.9 6.3 94.4 148 53 93.7 24.1 21.2

12 60 M OD Pseudophakic RRD 39 12 CF3m CF3m 20.3 23.4 3.1 6.3 6.3 120 35.8 294 16.3 20.5 15.2 152

13 54 M OS Pseudophakic RRD 21 13 20/200 20/120 22.7 68 0 1.5 2.6 23.2 31.9 121 28 105 17.4 13.5

14 16 M OS Myopic RRD 15 11 20/160 20/160 15.6 58.6 12.5 7.8 6.3 10.5 37.4 121 18.7 46 13.9 41.5

15 32 M OS Myopic RRD 18 10 CF1m CF1.5m 14 39.1 11.7 43.8 2.1 9.1 15.6 213 68.7 138 22.9 49.2

16 47 M OS Pseudophakic RRD 31 13 20/160 20/160 3.9 16.2 6.3 16 8.7 40.8 34.3 112 21 69.4 24.9 61.2

17 85 M OS Traumatic RRD 17 16 CF1m CF2m 76 91.4 0.8 13.3 5.2 19.1 112 249 66.3 130 30 90.9

18 38 F OS Stickler syndrome 20 13 20/200 20/160 45.8 43 0 28.1 7.2 14.7 166 173 105 118 27 32.8

19 19 M OS Traumatic RRD 8 13 20/200 20/120 42.2 56.3 12 12.5 4.3 28.9 106 202 74 113 190 58.4

20 50 M OD Pseudophakic RRD 28 14 20/200 20/200 32.8 58.6 14.1 20.3 5.6 8.3 60.8 176 54.6 108 7.8 32.2

21 36 M OS Macular hole RD 25 11 CF5m 20/160 10.4 14.8 0.7 2.3 1.7 3.9 13.6 98.4 6.3 23 1.4 17

22 38 F OS Traumatic RRD 15 15 20/160 20/160 75 149 14.1 21.1 8.3 23.2 112 318 59.3 173 27.7 81.7

23 39 M OS Pseudophakic RRD 12 12 20/160 20/120 45.3 73.4 7 35.2 9.4 34.1 162 326 79.6 208 32.4 99.6

24 43 F OD Myopic RRD 29 12 CF5m CF5m 34.4 43.8 7.7 15.6 0.6 8.1 28.1 49.9 5.5 24.2 17.2 23.3

25 39 M OD Pseudophakic RRD 17 14 CF2m CF2.5m 7.7 24.9 8.1 11 2.2 7.9 12.5 35.9 3 10.9 2.1 17

26 55 M OS RRD 19 10 20/80 20/80 26.6 39.1 6 8.6 2.6 11.8 65.5 98.3 26.5 72.6 18.8 26.1

27 27 M OS Traumatic RRD 11 13 20/160 20/160 4.3 59.1 10.3 12.5 6 18.8 93.2 315 55.4 98 26.2 54.5

28 30 M OD Traumatic RRD 13 10 20/60 20/60 15 17.9 12.5 18.7 6.8 12.7 91 278 49 117 23 58

F, female; M, male; OD, right eye; OS, left eye; RRD, rhegmatogenous retinal detachment; BCVA, best-corrected visual acuity; CF, counting fingers; Pre, before silicone oil removal; Post, after silicone oil removal.